Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study
Edouard L. Fu, Marie Evans, Juan Jesús Carrero, et al.
BMJ (2021), pp. e066306-e066306
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1936
Nutritional status and the risk of malnutrition in older adults with chronic kidney disease – implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN
Giorgina Barbara Piccoli, Tommy Cederholm, Carla María Avesani, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 4, pp. 443-457
Open Access | Times Cited: 80
Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations
Edouard L. Fu, Andrew S. Levey, Josef Coresh, et al.
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 50
Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
Edouard L. Fu
Journal of the American Society of Nephrology (2023) Vol. 34, Iss. 8, pp. 1305-1314
Open Access | Times Cited: 49
Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population
Edouard L. Fu, Josef Coresh, Morgan E. Grams, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 1, pp. 119-128
Open Access | Times Cited: 44
Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials
Harrison J Hansford, Aidan G Cashin, Matthew D. Jones, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2336023-e2336023
Open Access | Times Cited: 34
Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations
Juan Jesús Carrero, Edouard L. Fu, Søren Viborg Vestergaard, et al.
Kidney International (2022) Vol. 103, Iss. 1, pp. 53-69
Open Access | Times Cited: 32
Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care
Edouard L. Fu, Andrew S. Levey, Josef Coresh, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 4, pp. 694-706
Open Access | Times Cited: 19
Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus Cohort
Rona Lujan, Rachel Buchuk, Gili Focht, et al.
Gastroenterology (2024) Vol. 166, Iss. 5, pp. 815-825.e22
Closed Access | Times Cited: 8
Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure
Maria E. Montez‐Rath, I‐Chun Thomas, Vivek Charu, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 9, pp. 1233-1243
Closed Access | Times Cited: 7
The Clone-Censor-Weight Method in Pharmacoepidemiologic Research: Foundations and Methodological Implementation
Charles Gaber, Kent A. Hanson, Sodam Kim, et al.
Current Epidemiology Reports (2024) Vol. 11, Iss. 3, pp. 164-174
Closed Access | Times Cited: 6
Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps
Manuel Gomes, Alex Turner, Cormac Sammon, et al.
Value in Health (2024) Vol. 27, Iss. 5, pp. 623-632
Open Access | Times Cited: 5
Update of dialysis initiation timing in end stage kidney disease patients: is it a resolved question? A systematic literature review
Xiaoyan Jia, Xueqing Tang, Yunfeng Li, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
Bartłomiej Dąbek, Jill Dybiec, Weronika Frąk, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2746-2746
Open Access | Times Cited: 11
Impact of early initiation of renal replacement therapy in patients on venoarterial ECMO using target trial emulation with Japanese nationwide data
Toshihiro Kubo, Tomonori Takeuchi, Norihiko Inoue, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
First-year mortality in incident dialysis patients: results of the Peridialysis study
James Heaf, Maija Heiro, Aivars Pētersons, et al.
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Step-by-step causal analysis of EHRs to ground decision-making
Matthieu Doutreligne, Tristan Struja, J. Abecassis, et al.
PLOS Digital Health (2025) Vol. 4, Iss. 2, pp. e0000721-e0000721
Open Access
A Comparison of Hospitalization Outcomes Between Peritoneal Dialysis and Home Hemodialysis Patients by sex and race
George Worthen, Meghan Day, Leah E. Cahill, et al.
Kidney International Reports (2025)
Open Access
Impact of early versus conventional kidney replacement therapy initiation in tumor lysis syndrome: a target trial emulation
Justine Serre, Guillaume Mulier, Charlotte Boud’hors, et al.
Annals of Intensive Care (2025) Vol. 15, Iss. 1
Open Access
Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
Xiaojuan Li, Sonal Singh, Bahareh Rasouli, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 2
Open Access
Interleukin‐6 levels can be used to estimate cardiovascular and all‐cause mortality risk in dialysis patients: A meta‐analysis and a systematic review
Zeyu Chen, Yan Wang
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 9
The target trial framework in clinical epidemiology: principles and applications
Anthony Matthews, Jessica C. Young, Tobias Kurth
Journal of Clinical Epidemiology (2023) Vol. 164, pp. 112-115
Open Access | Times Cited: 9
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective
Massimo Torreggiani, Antioco Fois, Françoise Lippi, et al.
Clinical Kidney Journal (2022) Vol. 16, Iss. 4, pp. 647-661
Open Access | Times Cited: 13
Adequacy of haemodialysis and associated factors among patients with end-stage kidney disease in Tanzania
Abilah I. Bakari, James J. Yahaya, Boaz M. Matobogolo, et al.
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 2, pp. 287-295
Open Access | Times Cited: 2
Burden of diabetes and kidney disease attributable to non-optimal temperature from 1990 to 2019: A systematic analysis from the Global Burden of Disease Study 2019
Yan Liu, Haoyu Wen, Jianjun Bai, et al.
The Science of The Total Environment (2022) Vol. 838, pp. 156495-156495
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top